New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareGHRP-2 vs IGF-1 DES

GHRP-2 vs IGF-1 DES

Side-by-side comparison of key properties, dosing, and research.

Growth Hormone Peptides
GHRP-2
Anabolic & IGF
IGF-1 DES
Summary
GHRP-2 is a potent synthetic hexapeptide that stimulates growth hormone release by activating ghrelin receptors in the pituitary and hypothalamus. It produces one of the strongest GH pulses among GHRPs, though unlike Ipamorelin it does cause modest increases in cortisol and prolactin.
IGF-1 DES (also written DES(1-3)IGF-1) is a truncated form of IGF-1 missing the first three amino acids of the N-terminus. This structural change dramatically reduces its affinity for IGF binding proteins (IGFBPs), meaning a far greater fraction remains in its free, active form. IGF-1 DES is estimated to be 10x more potent than standard IGF-1 LR3 at the receptor level locally, making it particularly effective for site-specific muscle growth when injected intramuscularly.
Half-Life
15–60 minutes
~20–30 minutes (very short — designed for local action)
Admin Route
SubQ, Intranasal
IM, SubQ
Research
Typical Dose
100–300 mcg
20–50 mcg per injection site
Frequency
2–3 times daily
Once daily, post-workout
Key Benefits
  • Strong GH pulse stimulation
  • Increased IGF-1 levels
  • Enhanced muscle growth and recovery
  • Improved fat metabolism
  • Better sleep quality
  • Increased bone density
  • Enhanced appetite (less pronounced than GHRP-6)
  • Anti-aging effects via GH axis optimization
  • Estimated 10x greater potency at the receptor vs IGF-1 LR3 locally
  • Minimal IGFBP binding — nearly all active upon injection
  • Highly localized muscle growth effect when injected intramuscularly
  • Activates satellite cells for muscle fiber hyperplasia potential
  • Synergistic with GH peptides in post-workout anabolic protocols
  • Shorter half-life reduces systemic exposure vs IGF-1 LR3
  • Useful for site-specific muscle development
Side Effects
  • Increased appetite
  • Water retention
  • Elevated cortisol (modest)
  • Elevated prolactin (modest)
  • +2 more
  • Hypoglycemia (most significant risk — especially post-workout)
  • Localized muscle swelling at injection site
  • Potential for jaw/organ growth (acromegalic effects) with prolonged high-dose use
  • Carpal tunnel syndrome with high doses
  • +1 more
Stacks With